- Home
- BIDU vs ZTS Comparison
BIDU vs ZTS Comparison
Compare BIDU & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIDU | ZTS |
|---|---|---|
| Founded | 2000 | 1952 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.3B | 53.9B |
| IPO Year | 2005 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BIDU | ZTS |
|---|---|---|
| Price | $150.12 | $123.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $147.07 | ★ $174.60 |
| AVG Volume (30 Days) | 3.5M | ★ 4.8M |
| Earning Date | 02-17-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 1.70% |
| EPS Growth | N/A | ★ 11.64 |
| EPS | 3.25 | ★ 5.94 |
| Revenue | ★ $18,325,514,127.00 | $9,397,000,000.00 |
| Revenue This Year | N/A | $3.04 |
| Revenue Next Year | $4.92 | $4.96 |
| P/E Ratio | $46.04 | ★ $21.00 |
| Revenue Growth | N/A | ★ 2.68 |
| 52 Week Low | $74.71 | $115.25 |
| 52 Week High | $154.29 | $177.40 |
Technical Indicators
Market Signals| Indicator | BIDU | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 65.08 | 44.35 |
| Support Level | $145.64 | $123.32 |
| Resistance Level | $154.29 | $126.50 |
| Average True Range (ATR) | 4.62 | 2.89 |
| MACD | 0.55 | -0.25 |
| Stochastic Oscillator | 79.00 | 18.57 |
Price Performance
Historical ComparisonAbout BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 70% of core revenue from online marketing services from its search engine in 2024. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.